|
Succinimido–Ferrocidiphenol Complexed with Cyclodextrins Inhibits Glioblastoma Tumor Growth In Vitro and In Vivo without Noticeable Adverse Toxicity
Feten Najlaoui
,
Benoît Busser
,
Germain Sotoing Taïwe
,
Pascal Pigeon
,
Nathalie Sturm
et al.
Journal articles
hal-03736856v1
|
|
Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues
Emilie Belissa
,
Thibault Vallet
,
Sandra Laribe-Caget
,
Alain Chevallier
,
François-Xavier Chedhomme
et al.
Journal articles
hal-02922911v1
|
|
A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population
Thibault Vallet
,
Emilie Belissa
,
Sandra Laribe-Caget
,
Alain Chevallier
,
François-Xavier Chedhomme
et al.
Journal articles
hal-01793642v1
|
|
Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives
Feten Najlaoui
,
Pascal Pigeon
,
Sonia Aroui
,
Mylène Pezet
,
Lucie Sancey
et al.
Journal articles
hal-01861749v1
|
|
Spray-dried microparticles of glutathione and S-nitrosoglutathione based on Eudragit® FS 30D polymer
S. Shah
,
M. Socha
,
C. Sejil
,
Stéphane Gibaud
Journal articles
hal-01875168v1
|
|
The effect of intravenous isosorbide dinitrate in acute decompensated heart failure in hospital
Jérémy Chambord
,
David Attivi
,
Thuus Véronique
,
Claire Zeghmouli
,
Stéphane Gibaud
et al.
Journal articles
hal-01503313v1
|
|
Thiomers and their potential applications in drug delivery
Kifayat Ullah Ullah Shah
,
Shefaat Ullah Shah
,
Naz Dilawar
,
Gul Majid Khan
,
Stéphane Gibaud
et al.
Journal articles
hal-01377809v1
|
|
Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines
Shefaat Ullah Shah
,
Marie Socha
,
Isabelle Fries
,
Stéphane Gibaud
Journal articles
hal-01288115v1
|
|
Phthalimido-ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity
Feten Najlaoui
,
Pascal Pigeon
,
Zaineb Abdelkafi
,
Sebastien Leclerc
,
Pierrick Durand
et al.
Journal articles
hal-01218567v1
|
|
Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor
Shefaat Ullah Shah
,
Nuno Martinho
,
Marie Socha
,
Catarina Pinto Reis
,
Stéphane Gibaud
et al.
Journal articles
hal-01280370v1
|
|
Effect of intravenous hydration in patients receiving bisphosphonate therapy
David Attivi
,
Gaétan Kosmalski
,
Claire Zeghmouli
,
Stéphane Gibaud
Journal articles
hal-01169102v1
|
|
Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?
David Attivi
,
Stéphane Gibaud
Journal articles
hal-01291788v1
|
|
The antitumor effects of an arsthinol–cyclodextrin complex in a heterotopic mouse model of glioma
Selma Becherirat
,
Marie-Claire Lanhers
,
Marie Socha
,
Mehdi Yemloul
,
Alain Astier
et al.
Journal articles
hal-01169157v1
|
|
Characterization of mitotane (o,p′-DDD) – cyclodextrin inclusion complexes: Phase-solubility method and NMR
R. Alfonsi
,
D. Attivi
,
A. Astier
,
Marie Socha
,
S. Morice
et al.
Journal articles
hal-01290439v1
|
|
Microemulsions for oral administration and their therapeutic applications.
Stéphane Gibaud
,
David Attivi
Journal articles
hal-00706176v1
|
|
Melarsoprol Cyclodextrin Inclusion Complexes as Promising Oral Candidates for the Treatment of Human African Trypanosomiasis
Jean Rodgers
,
Amy Jones
,
Stéphane Gibaud
,
Barbara Bradley
,
Christopher Mccabe
et al.
Journal articles
hal-00689712v1
|
|
Speciation of arsenic in urine following intravenous administration of arsthinol in mice.
Imane Ajana
,
Alain Astier
,
Stéphane Gibaud
Journal articles
hal-00689713v1
|
|
Development of microemulsion of mitotane for improvement of oral bioavailability.
David Attivi
,
Imane Ajana
,
Alain Astier
,
Béatrice Demoré
,
Stéphane Gibaud
et al.
Journal articles
hal-00689714v1
|
|
Arsenic-Based Drugs: From Fowler’s Solution to Modern Anticancer Chemotherapy
Stéphane Gibaud
,
Gérard Jaouen
Journal articles
hal-01395677v1
|
|
Arsthinol nanosuspensions: pharmacokinetics and antileukemic activity on NB4 promyelocytic leukemia cells
Imane Ajana
,
Alain Astier
,
Stéphane Gibaud
Journal articles
hal-00689719v1
|
|
Comparison of nanosuspensions and hydroxypropyl-beta-cyclodextrin complex of melarsoprol: pharmacokinetics and tissue distribution in mice.
Siham Ben Zirar
,
Alain Astier
,
Marc Muchow
,
Stéphane Gibaud
Journal articles
hal-00399636v1
|
|
Pharmacokinetics and tissue distribution of the antileukaemic organoarsenicals arsthinol and melarsoprol in mice
Siham Ben Zirar
,
Stéphane Gibaud
,
Camut Alexandra
,
Alain Astier
Journal articles
hal-01395675v1
|
|
Organoarséniés dérivés du 2-phényl- [1,3,2]dithiarsolane-4-yl)-méthanol (AsIII) à propriétés antileucémiques : des trypanosomicides aux anticancéreux
Stéphane Gibaud
,
A. Astier
Journal articles
hal-00399635v1
|
|
Cyclodextrin inclusion complexes of the central analgesic drug nefopam.
H. Brun
,
M. Paul
,
N. Razzouq
,
M. Binhas
,
Stéphane Gibaud
et al.
Journal articles
hal-00399631v1
|
|
(2-Phenyl-[1,3,2]dithiarsolan-4-yl)-methanol derivatives show in vitro antileukemic activity
Stéphane Gibaud
,
Raphaël Alfonsi
,
Pierre Mutzenhardt
,
Isabelle Fries
,
Alain Astier
et al.
Journal articles
hal-00125073v1
|
|
Melarsoprol-cyclodextrins inclusion complexes.
Stéphane Gibaud
,
Siham Ben Zirar
,
Pierre Mutzenhardt
,
Isabelle Fries
,
Alain Astier
et al.
Journal articles
hal-00399630v1
|
|
Poly(epsilon-caprolactone) and Eudragit microparticles containing fludrocortisone acetate.
Stéphane Gibaud
,
Najim Jabir Al Awwadi
,
Camille Ducki
,
Alain Astier
International Journal of Pharmaceutics, 2004, 269 (2), pp.491-508
Journal articles
hal-00399629v1
|
|
Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods.
Stéphane Gibaud
,
Aurélie Bonneville
,
Alain Astier
International Journal of Pharmaceutics, 2002, 242 (1-2), pp.197-201
Journal articles
hal-00399627v1
|
|
Slow-release melarsoprol microparticles.
Stéphane Gibaud
,
Adela Gaia
,
Alain Astier
International Journal of Pharmaceutics, 2002, 243 (1-2), pp.161-6
Journal articles
hal-00399626v1
|
|
Ciblage de la moelle osseuse à l'aide de nanoparticules de polyalkylcyanoacrylate
S. Gibaud
,
C. Weingarten
,
J. P. Andreux
,
P. Couvreur
Annales Pharmaceutiques Françaises, 1999, 57 (4), pp.324-31
Journal articles
hal-00399628v1
|
|
Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF).
S. Gibaud
,
Chloé Rousseau
,
C. Weingarten
,
R. Favier
,
L. Douay
et al.
Journal of Controlled Release, 1998, 52 (1-2), pp.131-9
Journal articles
hal-00399625v1
|
|
Polyisobutylcyanoacrylate nanoparticles as drug carriers: influence of sulfur dioxide on the physico-chemical characteristics of ciprofloxacin- and doxorubicin-loaded nanoparticles
Marie-Estelle Page-Clisson
,
Stéphane Gibaud
,
Huguette Pinto-Alphandary
,
Colette Weingarten
,
Patrick Couvreur
et al.
Journal articles
hal-01383588v1
|
|
Splenic trapping of nanoparticles: complementary approaches for in situ studies.
M. Demoy
,
Stéphane Gibaud
,
J. P. Andreux
,
C. Weingarten
,
B. Gouritin
et al.
Pharmaceutical Research, 1997, 14 (4), pp.463-8
Journal articles
hal-00689718v1
|
|
Cells involved in the capture of nanoparticles in hematopoietic organs.
S. Gibaud
,
M. Demoy
,
J. P. Andreux
,
C. Weingarten
,
B. Gouritin
et al.
Journal articles
hal-00399624v1
|
|
Increased bone marrow toxicity of doxorubicin bound to nanoparticles.
S. Gibaud
,
J. P. Andreux
,
C. Weingarten
,
Maurice Renard
,
P. Couvreur
et al.
European Journal of Cancer, 1994, 30A (6), pp.820-6
Journal articles
hal-00399622v1
|
|
Increased bone marrow toxicity of doxorubicin bound to nanoparticles
Stéphane Gibaud
,
Andreux Jean-Paul
,
Colette Weingarten
,
Michèle Renard
,
Patrick Couvreur
et al.
Journal articles
hal-01383605v1
|
|
Detection of bacterial adenosine triphosphate through bioluminescence, applied to a rapid sterility test of injectable preparations
F C Decool
,
V Goury
,
A Tibi
,
S Gibaud
,
F Vincent
et al.
Journal articles
hal-01383025v1
|